Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012
AUG 2, 2012 - 16:15 ET
SAN FRANCISCO, CA--(Marketwire - August 2, 2012) - Medivation, Inc. (
Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
Chief Business & Financial Officer
Sr. Director, Investor Relations